Toronto, Ontario–(Newsfile Corp. – January 17, 2022) – “West Island Brands Inc.” (CSE: WIB) (FSE: 39N0) (OTCQB: WIBFF) (“West Island” or the “Company”) is pleased to announce that the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. doing business as de Culture de l’Ouest-de-l’Île (“West Island Culture”) has signed a letter of intent “LOI” with the Société Québécoise Du Cannabis “SQDC”. The SQDC is the only distributor and retailer of legal cannabis in the province of Quebec. Quebec is the second largest province in Canada.
West Island Culture has been approved for a listing of four new SKUs. Two of the approved strains are products sold under the premium brand OUEST™. The strains are premium cannabis with a high THC content approaching 30 percent and terpene levels averaging above 3 percent. OUEST™ brand products are high quality products.
West Island Culture will also feature two strains under the CITIZEN™ label. As the name suggests, this is a reasonably priced flower brand. Offering consumers high-quality products featuring a terpene-rich product list.
West Island Brands CEO Boris Ziger says, “We are extremely pleased to introduce our OUEST™ brand of premium cannabis and our CITOYEN™ brand to our home province of Quebec. As we bring new products to the province, we hope that we can serve Quebec consumers well with unique products, by a Quebec-based company. »
Management continues to aggressively expand the Company’s commercial and production footprint into other Canadian provinces.
About “West Island Brands”
West Island is a multifaceted innovative company in the field of cannabis in Quebec. Its subsidiary, Biotechnologie RoyalMax Canada Inc. (Culture de l’Ouest-de-l’Île) is licensed by Health Canada based in Dorval, Quebec, with a license for cultivation, processing (“processing”) , medical sales and sales. The Company continues to work with Yunify Natural Technologies, a Quebec-based health and personal care research and innovation company, to develop exclusive products for the West Island Culture, including topicals and ionic mists. Through its acquisition of Trichome Treats, a chocolatier, the Company intends to introduce edibles into the West Island Culture product line.
For more information about West Island Brands, please visit the website at: westislandbrands.com
On behalf of the Board of Directors
WEST ISLAND CULTURE INC.
Boris Ziger, CEO & President
The Company’s public filings may be viewed at www.sedar.com and www.thecse.com.
For more information, please contact:
Boris Ziger, CEO:
Email: [email protected]
Disclaimer for forward-looking information
Certain information contained in this press release may constitute forward-looking information. This information is based on current expectations which are subject to important risks and uncertainties which are difficult to predict. Actual results could differ materially from the results suggested in the forward-looking statements. The Company undertakes no obligation to update any forward-looking statements or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until applicable securities laws to the Company require it. Additional information on risks and uncertainties can be found in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the CSE policies) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/110215